Previous article![]( "Top 25 Indian Pharma Companies by Revenues in 2024")
Next article![]( "India’s Medical Devices Market: Strategic Implications and Key Investors")
Tuesday, June 2, 2026
29.9
C
Bengaluru
Hot topics
Finding the middle ground for Doctor-Stakeholder Relationship
Healthcare systems around the world differ – public, private or a mix of both public and private (like in India). With all the variance in healthcare delivery models, the risks to healthcare professionals remain universal: needle injuries to litigations to episodes of threats/ violence
Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?
Transparency, Trust, and the Problem of “Invisible Evidence” in...
Going Digital – What Indian Pharma C-Suite has to Say
Any transformational initiative must be driven by the CEO...
Tariffs and Indian Generics: Is Trump Cutting His Nose to Spite His Face?
Trump’s Tariffs Threaten US Drug Affordability The Value of...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Hot topics
How Did Telma Become a 1000+ Cr Brand?
The untold story of Glenmark's phenomenal success in building...
Blinkit, Zepto, Instamart: Who Will Own India’s At‑Home Diagnostics Market?
India’s diagnostics market is undergoing a quiet but profound...
Violence Against Doctors: Doctor-Patient Relationship Bruised and Battered
If a business fails, it was an idea that didn’t work. If treatment fails – it must be a botch up. A broken gadget may be beyond repair, but not a patient in a doctor’s hands. From such ungraded expectations stems the potential for things to take an ugly turn.
An unwanted profession dealing with an unwanted condition, namely Ill health:
If possible, we would wish away death and diseases, hospitals and doctors. A hospital is not a holiday resort, but it too costs money. And the scenario of an adverse outcome like death simply becomes unacceptable.
Coughing All the Way to the Bank: The High Cost of India’s Booming Cough Syrup Market
India’s cough syrup market, worth over ₹21,800 crore in...
Are Indian Pharma Business Leaders Adopting Digital Transformation?
We will need to find a way to bring together the capabilities of the Medical Rep, the changed scenario of the visit and the ways we can reach doctors into one single strategy rather than looking at the physical and the digital parts separately. Our medical reps will continue to be the core of our promotion, and our digital strategy will need to empower them to not only do a better call but also support their efforts by building processes that will help them beyond the few minutes that they spend in the Clinic. Marketing budgets will have to move away from conventional investments and also think beyond hardware to increase digital engagement.
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Newsletter
Get important news delivered directly to your inbox and stay connected!